C-MER MEDICAL (03309) spent 366,400 Hong Kong dollars on November 5 to repurchase 204,000 shares.
Xima Medical (03309) announced that the company spent HK$366,400 on a buyback on November 5, 2025.
C-MER MEDICAL (03309) announced that the company repurchased 204,000 shares on November 5, 2025, with a total investment of 366,400 Hong Kong dollars. The repurchase price per share was 1.79-1.81 Hong Kong dollars.
Related Articles
HBM HOLDINGS-B (02142) Signs Evaluation and Licensing Agreement with UMOJA BIOPHARMA
ASIARAY (01993) and Dandelion in Zhejiang Ya Tie entered into an advertising agreement.
HSBC HOLDINGS(00005): Conditional rewards granted.
HBM HOLDINGS-B (02142) Signs Evaluation and Licensing Agreement with UMOJA BIOPHARMA
ASIARAY (01993) and Dandelion in Zhejiang Ya Tie entered into an advertising agreement.
HSBC HOLDINGS(00005): Conditional rewards granted.
RECOMMEND
Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025
Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025
Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025
